Harvard Bioscience, Inc. (HBIO) Reports Q4 Earnings of $0.07; Guides FY12, Q1 EPS
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Join SI Premium – FREE
Harvard Bioscience, Inc. (NASDAQ: HBIO) reported Q4 EPS of $0.07, versus $0.11 reported last year. Revenue for the quarter came in at $29.03 million, versus $29.52 million reported last year.
Harvard Bioscience, Inc. sees FY2012 EPS of $0.26-$0.29.
Harvard Bioscience, Inc. sees FY2012 EPS of $0.04-$0.05.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
Harvard Bioscience, Inc. sees FY2012 EPS of $0.26-$0.29.
Harvard Bioscience, Inc. sees FY2012 EPS of $0.04-$0.05.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- UBS Downgrades FANUC Corp (6954:JP) (FANUY) to Neutral
- Morgan Stanley Upgrades Oil India Ltd. (OINL:IN) to Equalweight
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
